Structured Summary
Abstract
Recombinant human monoclonal antibody that binds to and inhibits the function of the EPIDERMAL GROWTH FACTOR RECEPTOR. It is used in the treatment of EGFR-expressing metastatic colorectal cancer that expresses wild-type ras gene (see GENES, RAS).
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
7 entry terms
- ABX-EGF MAb
- ABX-EGF Monoclonal Antibody
- Panitumumab Antibody, Human
- ABX EGF Monoclonal Antibody
- Human Panitumumab Antibody
- Monoclonal Antibody, ABX-EGF
- Vectibix
MeSH Record
Aspects Covered
24 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2019 (2005)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Panitumumab. Medical Subject Headings (MeSH). 2026. Unique ID D000077544. http://id.nlm.nih.gov/mesh/2026/D000077544
- Panitumumab. In: Wikipedia. https://en.wikipedia.org/wiki/Panitumumab
- Panitumumab. In: Wikidata. https://www.wikidata.org/wiki/Q417775